MedPath

EFFIK

🇫🇷France
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 4:1

Drug Approvals

1

CIMA_AEMPS:1

Drug Approvals

GESTINYL 20/75 microgramos comprimidos recubiertos

Approval Date
Jul 14, 2025
CIMA_AEMPS

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 4
1 (100.0%)

Interest of Intravaginal Electro-stimulation at Home by GYNEFFIK® Compared to Usual Care in Incontinent Patients With Prior Perineal Reeducation

Phase 4
Conditions
Urinary Mixed Incontinence
Urinary Stress Incontinence
First Posted Date
2014-01-07
Last Posted Date
2014-01-07
Lead Sponsor
Effik
Target Recruit Count
163
Registration Number
NCT02029027
Locations
🇫🇷

Marc Bernardini, Marseille, France

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.